Hoth Therapeutics, Inc. (HOTH)
NASDAQ·Healthcare·Biotechnology
$1.41
—
Mkt Cap $13.13M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$1.41
—
Mkt Cap $13.13M
Buy
2
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —